PHARMACEUTICAL PRODUCT DEVELOPMENT INC Comprehensive Income
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Comprehensive Income of $11.30 million for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-09-30 was $11.30M, a 83.33% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-06-30 was $53.80M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2010-09-30 was $67.82M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2010-06-30 was -$616.00K.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month |
|---|---|---|---|
| 2011-09-30 | $11.30M 10-Q · filed 2011-11-02 | $65.10M derived: sum of 2 quarters · filed 2011-11-02 | $117.95M 10-Q · filed 2011-11-02 |
| 2011-06-30 | $53.80M 10-Q · filed 2011-08-04 | $106.64M 10-Q · filed 2011-08-04 | |
| 2010-09-30 | $67.82M 10-Q · filed 2011-11-02 | $67.21M derived: sum of 2 quarters · filed 2011-11-02 | $70.24M 10-Q · filed 2011-11-02 |
| 2010-06-30 | -$616.00K 10-Q · filed 2011-08-04 | $2.42M 10-Q · filed 2011-08-04 |